However, since TNBCs constitute about 15% of all breast cancers, while hormone receptor-positive breast cancers comprise about 70% of all breast cancers, there is actually a greater number of hormone receptor-positive breast cancer patients who are gBRCAMUT. This evidence concerns the gene NR4A1 and breast cancer.